UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006079
Receipt number	R000007195
Scientific Title	A cohort study in patients with StageIIIB/IVnon-small cell lung cancer, who had treated as 1st-line Conbination therapy of Carboplatin/Paclitaxel/Bavacizumab, and 2nd-line by Erlotinib
Date of disclosure of the study information	2011/07/30
Last modified on	2018/02/19 15:13:23

---